Effects of glucagon-like peptide-I on glucose turnover in rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 270, Issue 6 33-6, 1996, Pages

  Van Dijk, Gertjan ^b   Lindskog, Stefan ^b   Holst, Jens J ^b   Steffens, Anton B ^b   Ahrén, Bo ^a  

^a LUND UNIVERSITY   (Sweden)

^b NONE

Author keywords

fasting; glucagon secretion; insulin secretion; tritiated glucose

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; INSULIN RELEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029850604     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.270.6.e1015     Document Type: Article

References (31)

1. Ahrén, B. Insulinotropic action of truncated glucagon-like peptide-1 in mice. Acta Physiol. Scand. 153: 205-206, 1995.
2. Ahrén, E. Antidiabetogenic action of truncated glucagon-like peptide-1 in mice. Endocrine 3: 367-369, 1995.
3. Ahrén, B., and T. Fridolf. GLP-1-(7-36)-amide and insulin secretion. In: Vasoactive Intestinal Peptide, Pituitary Adenylate Cyclase Activating Polypeptide and Related Regulatory Peptides. From Molecular Biology to Clinical Applications, edited by G. Rosselin. London: World Scientific, 1994, p. 400-417.
4. Ahrén, B., S. Lindskog, G. van Dijk, A. J. W. Scheurink, and A. B. Steffens. Effects of GLP-1 and 2,5-anhydro-D-mannitol on insulin secretion and plasma glucose in mice. Endocr. Res. 21: 583-594, 1995.
5. D'Alessio, D. A., S. E. Kahn, C. R. Leusner, and J. W. Ensinck. Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J. Clin. Invest. 93: 2263-2266, 1994.
6. Fehmann, H. C., R. Göke, and B. Göke. Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose-dependent insulin releasing polypeptide. Endocr. Rev. 16: 390-410, 1995.
7. Ferrannini, E. and L. C. Groop. Hepatic glucose production in insulin-resistant states. Diabetes Res. 5: 711-726, 1989.
8. Fridolf, T. and B. Ahrén. GLP-1(7-36)amide stimulates insulin secretion in rat islets: studies in the mode of action. Diabetes Res. 16: 185-191, 1991.
9. (7-36) amide: influences on basal and stimulated insulin and glucagon secretion in the mouse. Pancreas 6: 208-215, 1991.
10. Göke, R., H. C. Fehmann, and B. Göke. Glucagon-like peptide-1(7-36)amide is a new incretin/enterogastrone candidate. Eur. J. Clin. Invest. 21: 135-144, 1991.
11. Göke, R., B. Wagner, H. C. Fehmann, and B. Göke. Glucose dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas. Res. Exp. Med. 193: 97-103, 1993.
12. Gutniak, M., C. Ørskov, J. J. Holst, B. Ahrén, and S. Efendic. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326: 1316-1322, 1992.
13. Havel, P. J. and G. J. Taborsky, Jr. The contribution of autonomic nervous system to changes of glucagon and insulin secretion during hypoglycemic stress. Endocr. Rev. 10: 332-350, 1989.
14. Hendrick, G. K., A. Gjinovci, L.-A. Baxter, S. Mojsov, C. B. Wollheim, J. F. Habener, and G. C. Weir. Glucagon-like peptide-1-(7-37) suppresses hyperglycemia in rats. Metab. Clin. Exp. 42: 1-6, 1993.
15. Holst, J. J., C. Ørskov, O. V. Nielsen, and T. W. Schwartz. Truncated glucagon-like peptide-I, an insulin releasing hormone from the distal gut. FEBS Lett. 211: 169-174, 1987.
16. Hvidberg, A., M. Toft-Nielsen, J. Hilsted, C. Ørskov, and J. J. Holst. Effect of glucagon-like peptide-1 (proglucagon 78-107-amide) on hepatic glucose production in healthy man. Metab. Clin. Exp. 43: 104-108, 1994.
17. Jia, X., J. C. Brown, P. Ma, R. A. Pederson, and C. H. S. McIntosh. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E645-B651, 1995.
18. Kreymann, B., M. A. Ghatei, G. Williams, and S. R. Bloom. Glucagon-like peptide 1 (7-36): a physiological incretin in man. Lancet 2: 1300-1303, 1987.
19. Liljenquist, J. E., G. L. Mueller, A. D. Cherrington, J. M. Perry, and D. Rabinowitz. Hyperglycemia per se can inhibit hepatic glucose production in man. J. Clin. Endocrinol. Metab. 48: 171-175, 1979.
20. Nauck, M. A., M. M. Heimesaat, C. Ørskov, J. J. Holst, R. Ebert, and W. Creutzfeldt. Preserved incretin activity of glucagon-like peptide 1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 91: 301-307, 1993.
21. Nauck, M. A., N. Kleine, C. Ørskov, J. J. Holst, B. Willms, and W. Creutzfeldt. Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36: 741-744, 1993.
22. Ørskov, C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 35: 701-711, 1992.
23. Ørskov, C., O. V. Nielsen, and J. J. Holst. Effect of truncated glucagon-like peptide-1 (proglucagon 78-107 amide) on endocrine secretion from pig pancreas, antrum and non-antral stomach. Endocrinology 123: 2009-2013, 1988.
24. Ørskov, C., L. Rabenhøj, H. Kofod, A. Wettergren, and J. J. Holst. Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes 43: 535-539, 1994.
25. Proietto, J., F. Rohner-Jeanrenaud, E. Ionescu, J. Terrettaz, J.-F. Sauter, and B. Jeanrenaud. Non-steady-state measurement of glucose turnover in rats by using a one-compartment model. Am. J. Physiol. 252 (Endocrinol. Metab. 15): E77-E84, 1987.
26. Qualmann, C., M. A. Nauck, J. J. Holst, C. Ørskov, and W. Creutzfeldt. Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7-36 amide] in the fasting state in healthy subjects. Acta Diabetol. 32: 13-16, 1995.
27. Steele, R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad. Sci. 82: 420-430, 1959.
28. Steffens, A. B. A method for frequent sampling of blood and continuous infusions of fluid in the rat without disturbing the animals. Physiol. Behav. 4: 833-836, 1969.
29. Van Dijk, G., A. E. Bottone, A. B. Steffens, and J. H. Strubbe. Hormonal and metabolic effects of paraventricular hypothalamic administration of neuropeptide Y during rest and feeding. Brain Res. 660: 96-103, 1994.
30. Vissing, J., B. Sonne, and H. Galbo. Role of metabolic feedback regulation in glucose production of running rats. Am. J. Physiol. 255 (Regulatory Integrative Comp. Physiol. 24): R400-R406, 1988.
31. Widmann, C., W. Dolci, and B. Thorens. Desensitization and phosporylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate. Mol. Endocrinol. 10: 62-75, 1996.